Browse
Pseudo-electrolyte disorders are laboratory artifacts, and failure to recognize this entity can lead to inadvertent treatment. The hallmark of pseudo-electrolyte disorders is that the patient does not exhibit classic signs or symptoms of the underlying electrolyte abnormality. This should prompt clinicians to rule out pseudo-electrolyte disorders before initiating therapy. Here, we highlight pseudo-electrolyte disorders seen in onconephrology practice.
A
Sickle cell disease and sickle cell trait are associated with several kidney abnormalities. The inner medullary environment of the kidney with low oxygen tension, hyperosmolarity, and acidemia is an ideal setup for hemoglobin polymerization and sickling. Repeated hemolysis, vaso-occlusive episodes, subsequent reperfusion injury, oxidative stress, and inflammation lead to acute and chronic kidney disease (CKD) (
Kidney manifestations of sickle cell disease
Glomerular hyperfiltration and lower mean arterial pressure occur in early years of life. With advancing age,
Chronic hypertension occurs in at least 2% of pregnancies in the United States and is associated with high rates of preeclampsia and other adverse pregnancy outcomes. There is ongoing debate over treatment strategies: Continuing antihypertensive therapy during pregnancy reduces the risk of severe hypertension but has not previously been shown to improve maternal, fetal, or neonatal outcomes.
Findings from a new trial reported in
The Chronic
Prediction models can process factors that modify patient risk and transform them into a single probabilistic prediction that can be used to help patients and doctors make good choices and fairly allocate care.
Acceptance into PMC, MEDLINE, and ESCI is crucial for the success of a scholarly journal, and being recognized at this level gives credibility to the content and increases its discoverability.
The 4i platform provides ETC participants with a secure and efficient way to receive notifications about their attributed beneficiaries, Modality Performance Score, and Performance Payment Adjustment.
The start of a new year often signals a time for reflection. As we move through 2022, we again may find ourselves asking: What is the state of nephrology research? How are trainees fairing as they build their own independent careers in this field? There are many sources of support that assist trainees at all levels as they hone the skills necessary for scientific investigation. However, this career path is not without challenges, including, but not limited to, scientific investigation funding, time that is dedicated for investigation, support to build a professional network, and the current lack of diversity in
ASN plans to lead the kidney community in reconsidering “every aspect of the future of nephrology” over the next 8 months, ASN President Susan E. Quaggin, MD, said in a March letter to the American Board of Internal Medicine (ABIM) Nephrology Board and the Accreditation Council for Graduate Medical Education (ACGME).
Quaggin was responding to separate messages from the two organizations asking for ASN's input on major revisions of their certification and training program requirements.
In a letter to Quaggin in January, the ABIM Nephrology Board wrote, “For some time the nephrology community has grappled with whether or not certain
“Doc, I was told I have stage 5 kidney disease. What happened to stages 1 through 4?”
Almost every nephrologist, including myself, has had this heartbreaking and far too common question asked of them by patients receiving their diagnosis of kidney disease for the first time. Even worse: A patient first learns about kidney function coincident with placement of a catheter to initiate urgent dialysis.
Not surprisingly, these diagnoses trigger a mixture of emotions: fear, anxiety, disbelief … anger. It is time we do better.
The first diagnosis of kidney disease as kidney failure is truly a failure—of the system.
According to surveys conducted by the Association of Chairs of Departments of Physiology, the percentage of Black faculty has averaged 1% for the past 20 years (
